🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Pfizer Inc.

PFE Healthcare
$27.72 +$0.07 (0.25%)
Market Cap: $157.99 B
Gurus Holding
21
Popularity Rank
#32
% of Shares Held
2.58%
Net Activity (Q2 2026)
+$106.47 M

Guru Ownership Trend

Guru Analysis for Pfizer Inc. (PFE)

Pfizer Inc. (PFE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 21 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.08 B.

Top institutional holders include Ken Fisher and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $106.47 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Diamond Hill Capital reduced exposure by 31.1%.

Key Holders

Top 5 by Value

$2.63 B
$445.02 M
$143.49 M
$52.48 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$288.31 M
Total Buy Value
New Buys 3
Additions 8
-$181.84 M
Total Sell Value
Reductions 9
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
10
Net Buyers
11

FAQs for Pfizer Inc. (PFE)

Major holders include Ken Fisher ($2.63 B), Cliff Asness ($445.02 M), Richard Pzena ($143.49 M). According to the latest reported data, 21 tracked investment managers collectively hold approximately 147.05 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $106.47 M, with 11 managers increasing positions and 10 managers reducing holdings.

During the most recent reporting period, 9 managers trimmed their positions, while 1 fully exited PFE. The total reported sell value was $181.84 M.

Yes, 3 managers opened new positions in PFE, and 8 increased their existing holdings. The total reported buy value was $288.31 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.78% Add 3.9% 109,067,291 $2.63 B Q2 2026
0.16% Add 56.2% 18,557,891 $445.02 M Q2 2026
0.42% Add 0.6% 5,958,922 $143.49 M Q2 2026
0.81% Reduce -31.1% 4,210,499 $101.39 M Q2 2026
0.12% Reduce -4.6% 2,179,317 $52.48 M Q2 2026
0.50% Add 0.1% 1,916,801 $46.16 M Q2 2026
0.95% Add 5.4% 1,043,900 $25.12 M Q2 2026
0.05% Reduce -12.9% 916,205 $22.06 M Q2 2026
0.02% New Buy 697,000 $16.78 M Q2 2026
0.10% Reduce -30.5% 642,123 $15.46 M Q2 2026
0.12% Reduce -3.1% 571,286 $13.76 M Q2 2026
1.75% Reduce -1.4% 268,200 $6.46 M Q2 2026
0.37% New Buy 231,000 $5.56 M Q2 2026
0.37% New Buy 231,000 $5.56 M Q2 2026
0.02% New Buy 180,092 $4.34 M Q2 2026
3.04% Reduce -7.1% 174,610 $4.2 M Q2 2026
0.25% Add 19.4% 117,155 $2.82 M Q2 2026
0.02% Add 2.2% 79,351 $1.93 M Q2 2026
0.02% Add 1.0% 69,662 $1.68 M Q2 2026
0.01% Reduce -5.8% 67,679 $1.63 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form